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What is already known on this topic? 
 Poor growth attainment in early childhood and early adolescence has been reported for 
extremely preterm survivors. 
 Growth data beyond adolescence are scarce in such populations. 
What this study adds? 
 EP participants remained shorter and lighter and had smaller head circumferences than 
reference data or term-born controls in adulthood, despite catch-up growth. 
 Trajectories in height and head circumference were similar in EP and control participants, 
but weight, and therefore BMI, rose faster among EP individuals. 
 Birth characteristics and neonatal feeding practices were related to growth over childhood 
to 19 years.   
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Abstract 
Objective: To investigate growth trajectories from age 2.5 to 19 years in individuals born before 26 
weeks of gestation (extremely preterm; EP) compared with term-born controls. 
Methods: Multilevel modelling of growth data from the EPICure Study, a prospective 1995 birth 
cohort of 315 participants born in the UK and Ireland and 160 term-born controls recruited at school 
age. Height, weight, head circumference and body mass index (BMI) z-scores were derived from UK 
standards at age 2.5, 6, 11 and 19 years. 
Results: 129 (42%) EP children were assessed at 19 years. EP individuals were on average 4.0 cm 
shorter and 6.8kg lighter with a 1.5 cm smaller head circumference relative to controls at 19 years. 
Relative to controls, EP participants grew faster in weight by 0.06 SD per year (95% CI 0.05 to 0.07), 
in head circumference by 0.04 SD (0.03 to 0.05), but with no catch-up in height. For the EP group, 
because of weight catch up between 6 and 19 years, BMI was significantly elevated at 19 years to 
+0.32 SD; 23.4% had BMI>25 kg/m2 and 6.3% >30 kg/m2 but these proportions were similar to those 
in control subjects. EP and control participants showed similar pubertal development in early 
adolescence, which was not associated with height at 19y in either study group. Growth through 
childhood was related to birth characteristics and to neonatal feeding practices. 
Conclusions: EP participants remained shorter and lighter and had smaller head circumferences than 
reference data or controls in adulthood but had elevated BMI.  
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Poor growth attainment in early childhood and early adolescence has been reported for extremely 
preterm survivors (EP; <26 weeks of gestation)1-3. Growth data beyond adolescence are scarce in 
such populations. Several studies have reported growth outcomes in young adulthood for very low 
birth weight (VLBW; <1500 g) or extremely low birth weight (ELBW; <1000 g) children4-8. However, 
the findings were in populations defined by birth weight rather than gestational age, which may 
introduce bias because more mature children with intrauterine growth restriction were included9. 
Additionally, these studies only included individuals born in the 1970s-1980s. Advances in perinatal 
and neonatal care in the 1990s markedly improved the survival rates of EP infants, which may 
impact long term growth. 
We conducted a longitudinal analysis of growth from infancy to early adulthood for individuals 
evaluated in the EPICure study, a large prospective, population-based cohort of EP births. At 2.5y 
and 6y, all main growth parameters were significantly below population norms2,3. The main objective 
of this paper was to investigate growth trajectories in EP children to 19 years compared with those 
of a term-born comparison group. Our secondary objectives were to explore the impact of neonatal 
variables and important childhood outcomes, and to examine pubertal development in early 
adolescence and its association with growth attainment in adulthood. We hypothesised that EP 
children would demonstrate poorer growth than controls in young adulthood, but that this might be 
offset by delayed puberty and catch up growth.  
Methods 
Participants. The EPICure cohort comprised all babies born at 25 completed weeks of gestation or 
less in all 276 maternity units in the UK and Ireland from March to December 1995. Recruitment of 
the cohort has been described in detail previously10-12; 315 survived to discharge and were followed 
at age 2.5, 6, 11 and 19 years. Nine deaths occurred between discharge and the 19-year assessment, 
at which 129 (42%) of EP participants were assessed. A flow chart detailing dropout and recruitment 
of controls has been published previously13. Written informed consent was obtained from parents 
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up to 11 years and from individual participants at 19 years. Ethical approval was obtained for each 
follow up assessment. The study at 19 years was approved by the South Central Hampshire A 
Research Ethics Committee (Ref: 13/SC/0514). 
Measures. Participants were invited for a comprehensive evaluation at 11 and 19 years, which 
included physical assessment of growth by a paediatrician or paediatric nurse. Assessors were not 
informed of the child’s group status. Weight, height and occipito-frontal head circumference were 
measured. Measurement at age 2.5 and 6 years has been described in detail previously2,3. At 11 and 
19 years, height was measured using a portable height measure; length or arm span was used in 
participants unable to stand. Weight was measured using standard paediatric metric scales and head 
circumference using a non-distensible LASS-O tape. All parents and children were asked to complete 
an anonymised questionnaire about pubertal development at 11 years based on Tanner staging14-16. 
Self-assessment can be validly used for large epidemiologic studies for evaluating sexual maturation 
in children, although studies of outcomes that are strongly dependent on precise staging of pubertal 
development must ensure correct assessment by standardized clinical examination17,18. Body mass 
index (BMI) was calculated as weight in kilograms divided by height in meters squared. Standard 
deviation scores (z-scores) for height, weight, BMI and head circumference were calculated at each 
age based on UK population norms19. Overweight and obesity were defined using internationally 
accepted cut-offs of 25 and 30 kg/m2 respectively19. 
Neonatal variables were obtained from the main study database, including gestational age, birth 
weight for gestational age (a measure of intrauterine growth), ethnicity (white vs other), neonatal 
brain injury (defined as moderate/severe injury: ventricular size >4mm over 97th 
centile/hemorrhage/cysts/ cystic leukomalacia or any unilateral/bilateral parenchymal problem13), 
enteral feeding begun before day 7 (yes vs no), and the number of weeks of steroid therapy for 
chronic lung disease. Cognitive outcomes have been reported previously11-13,20. 
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Statistical analysis. Data were analysed using Stata 15.1. Multilevel modelling was used to 
investigate growth trajectories from infancy to adulthood. It treats the data as having a hierarchical 
structure with observations at each time point nested within each individual, which allows 
adjustment for missing observations where the individual was not assessed. When comparing the EP 
and control groups, age was fitted as a random effect. This allows both the average level and the 
change in z-scores to vary between individuals. A group term was added as a fixed covariate to test 
for a difference in intercept between the EP and control groups. An interaction term between age 
and group was then added to test whether the EP and control groups differed in slope. The effects of 
sex were examined by adding them separately to the model as a fixed covariate and then as 
interactions with group. For a parameter to be retained in the model, it was required to have a p 
value <0.05. Similar analyses were then conducted within the EP group to test effects of neonatal 
variables. Analyses were first conducted in all participants with data available at any time point, and 
then restricted to those with complete longitudinal data only. Relationships between puberty and 
growth trajectories were also explored using multilevel modelling. 
As previously we had observed an association between cognitive scores and head circumference2, 
relationships of head size with cognition/attainment at different ages were analysed using multiple 
linear regression models. We adjusted for neonatal brain injury, gestational age and sex for EP 
participants, and sex for controls.  
Results 
Participants and attrition: Characteristics of EP participants and term-born controls by age of 
assessment are shown in table 1. Progressive loss to follow up occurred for the EPICure cohort over 
the period of 19 years, and similar attrition occurred in the control group. EP completers (no missing 
growth assessments) were more likely than non-completers (one or more missing assessments) to 
be from multiple births and to have parents with a non-manual occupation, and were less likely to 
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have severe motor disability at 2.5 years (online supplementary table S1) but in other respects the 
cohort included in this analysis were representative of the total original cohort. 
Growth trajectories: Mean z-scores for growth measures in EP participants were significantly below 
zero from age 2.5 to 19 years; at 19 years, height was -0.98 SD, weight -0.25 SD and head 
circumference -0.84 SD; because of discrepant catch up in weight rather than height, BMI z scores 
increased faster from 6 to 19 years to be on average 0.32 SD greater than population means (table 
1).  In the EP group the trajectory of weight (and therefore BMI) z-scores showed a greater relative 
increase between 6 and 11 years, with a subsequent similar trajectory to controls over adolescence 
to 19 years (figure 1). Trajectories in height and head circumference were similar in EP and control 
participants. Similar findings were present when compared to controls: at 19 years, on average EP 
individuals were 4.0 cm shorter and 6.8kg lighter with a 1.5 cm smaller head circumference relative 
to controls; mean BMI in EP individuals was 23.3 kg/m2 (95% CI 22.6 to 24.1); 23.4% (30/128) met 
criteria for overweight and 6.3% (8/128) for obese, and were not significantly different from controls 
in whom mean BMI was 24.7 kg/m2 (95% CI 23.3 to 26.1). There were no sex differences in either 
group. At 11 years, 13.8% (30/217) of EP children met criteria for overweight and 0.9% (2/217) for 
obese, lower than controls (overweight: 17.1%; obese: 4.0%), but the differences were not 
statistically significant (p=0.089). EP participants who were overweight or obese at 11 years were at 
higher risk of being overweight or obese at 19 years (RR [95% CI]: 3.16 [1.97, 5.07], p<0.001). 
From age 2.5 to 19 years, using multilevel modelling z scores for height were on average 0.83 SD 
lower in EP participants compared to controls, weight 0.94 SD lower, and head circumference 1.22 
SD lower (all p<0.001; table 2). Using multilevel modelling, EP participants on average showed catch-
up gain in weight by 0.06 SD per year (0.05 to 0.07), BMI by 0.08 SD (0.07 to 0.10), and head 
circumference by 0.04 SD (0.03 to 0.05; all p <0.001), but no evidence of catch-up in height. There 
were no significant differences between z scores of males and females for all four growth measures 
in either group at each age (table 2 & figure S1a).  
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Impact of neonatal variables  – We evaluated the influence of neonatal factors on growth over 19 
years within EP participants using multilevel models (Table 3). Birthweight for gestational age was 
related to height and head circumference trajectories (all p<0.001) and white ethnicity to height and 
weight at age 2.5, 6 and 11 years but not at 19 years (figure S1b). Gestational age, despite the 
narrow range among this group (23-25 weeks), was significantly related to head growth (p<0.001). 
The variable “enteral feeds begun before day 7” was positively related to all outcomes except for 
height at 19 years (figure S1c), but other neonatal variables, including neonatal brain injury and the 
use of long courses of postnatal steroid (commonly used in 1995), were not related to growth in this 
model. All analyses were repeated among participants who were examined at each age with 
essentially similar findings (tables S2 and S3). Some significances were reduced but the direction and 
magnitude of effects were similar. 
Puberty and growth in adulthood: EP boys and girls at age 11 reported similar pubertal 
development compared with term-born boys and girls. Proportions who had entered puberty were 
15% for boys in both groups, 40% for EP girls. This compared to 32% for term-born girls (p=0.301; 
table S4). At 11 years, EP and term-born girls (but not boys) who have entered puberty were 
significantly taller than prepubescent peers. In contrast, by 19 years, height did not differ with 
pubertal status at 11 years in either boys or girls for both groups (figure 2; table S5).  
Head size and cognition/attainment: In the EP group, reduced head circumference z-scores were 
positively correlated with lower IQ and attainment scores at each age, which remained significant 
after adjustment for neonatal brain injury, sex and gestational age, and after excluding participants 
with severe motor disability (coefficients ranging 1.98-5.67; table S6).  
Discussion 
We report growth trajectories from infancy to early adulthood in EP survivors born in 1995. Growth 
patterns in height and head circumference were similar in EP participants and term-born controls, 
but EP participants remained shorter and lighter and had smaller head circumferences than 
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reference data or controls. With the exception of height, multilevel modelling shows evidence of 
catch-up growth in the EP group throughout childhood and adolescence, for weight by 0.06 SD per 
year and head circumference by 0.04 SD. In this clinical cohort, catch up was greatest in weight, and 
therefore BMI, between 6 and 11 years but similar proportions of EP and control participants were 
considered overweight or obese at 19 years. We evaluated a range of possible influences on growth 
to 19 years. Pubertal status at 11y was not associated with final height but in the group that 
commenced enteral feeds in the first week, better childhood and adolescent growth was found. 
Head size was associated with IQ score at 19 years. 
It is hard to make direct comparisons with other studies of growth attainment in adulthood in 
preterm children, as they have focused on VLBW/ELBW survivors, which included children born at 
higher gestations who were small for gestational age and had a higher mean birthweight and 
gestational age4-6,8. This report supports findings from the Canadian cohort of 147 ELBW children6. In 
contrast, among 42 ELBW participants from Victoria, Australia average weight was attained by early 
adulthood4. A further study conducted in Cleveland, Ohio reported complete catch-up in weight 
among VLBW females in young adulthood, but not among males5. The authors argue that this might 
be related to the lesser neonatal and early childhood morbidity among VLBW females5. We did not 
find significant differences between males and females in any growth measure in either EP or 
control groups.   
Both groups showed similar pubertal development in early adolescence, in agreement with previous 
studies7,21,22. Pubertal status at 11 years was unrelated to final height in both groups, again in 
support of previous findings23,24.  Early sexual maturity has been reported in low-birth-weight 
(LBW)/VLBW girls 25,26, but this was not demonstrated in our study. We did not collect information 
on parental height or determine bone age, but final height is dependent on mid-parental height 4,21, 
although in very low birthweight children advanced bone age in adolescence may contribute to 
shorter height in adulthood22.   
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Irrespective of size at birth, mean BMI in the EP group and controls at age 19 was significantly above 
the 1990 UK population standards, indicating that they were relatively heavy for their height. In 
previous cohorts it normalised but was not significantly different from population norms4,6. We show 
greater relative catch-up in BMI among EP participants than among term-born controls over time, 
consistent with the Swedish cohort1. The rates of overweight (23%) and obesity (6%) for EP 
participants in young adulthood are much higher than those reported in the 1990 UK population at 
age 18 – around 10% for overweight and 1% for obesity19, but the findings are consistent with those 
among controls and may reflect secular trends. There is accumulating evidence that low birth weight 
together with rapid growth in weight or BMI in childhood is associated with increased risk for 
cardiovascular diseases in adult life27-30. We also show that EP participants being overweight/obese 
at 11 years were at increased risk of being overweight/obese at 19 years. Early interventions can 
help to prevent obesity among young people. 
Associations of subnormal head size with poor developmental outcomes have been reported for 
VLBW children at school age22,31. We show that the positive relationship between head size and 
cognitive outcomes persists into early adulthood, despite improved growth velocity in head 
circumference. Consistent with our previous reports2,3, head size in the EP cohort at 11 and 19 years 
continued to be significantly associated with birth characteristics, being smaller for babies born at 
lower gestational ages (0.46 SD per week) and those with low birthweight for gestation (0.38 SD per 
birthweight SD).  
Within the EP cohort, birth weight for gestational age predicted height and head size at all ages, 
indicating that intrauterine growth has an important effect on growth into adulthood. In adulthood, 
head size was smaller in EP participants receiving long courses of postnatal steroid. Short-term 
detrimental effects of long courses of postnatal steroid on growth have been reported in premature 
children2,3,32,33. EP children appeared to have better growth in weight and BMI in early adulthood 
following early introduction of enteral feeding. Nutritional practices varied greatly among neonatal 
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intensive care units, reflecting both lack of evidence and strong local traditions34. Our findings show 
an association but randomised trials are needed to show causation and this may reflect a group of 
individuals with less severe neonatal illness.  
The strength of this study lies in the longitudinal design with data collected at multiple ages. Other 
strengths are the inclusion of a comparison group and the use of multilevel modelling to partially 
account for attrition, and the validation analysis of individuals with complete follow-up. The major 
weakness is that the number of participants lost to follow-up increased over time and dropout was 
associated with markers of social disadvantage and disability. However, our findings were 
strengthened by the analysis of individuals with complete follow-up which corroborated the main 
results, and there were no significant differences in growth measures between participants with 
complete and incomplete data. Growth trajectories from participants with complete data were 
similar compared to all participants (figure S2). Controls were recruited at age 6 years, and thus we 
did not have measures in early childhood for comparison.  
In conclusion, impaired growth over the postnatal period among extremely preterm births, related 
to birth characteristics and feeding patterns, was reflected in lower linear growth and smaller head 
circumferences, associated with lower cognitive attainment over childhood to 19 years. In contrast, 
rapid increase in weight relative to height between 6 and 11 years led to elevated average BMI 
values in this group.  
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Table 1 Characteristics in extremely preterm (EP) participants and term-born controls by age of assessment  
Variables 
Whole cohort Age 2.5 years+ Age 6 years Age 11 years Age 19 years 
EP (n=315) 
EP (n=283) EP (n=241) Control (n=160) EP (n=219) Control (n=153) EP (n=129) Control (n=65) 
At birth EDD 
Age (years) Mean 
(range) 
- - 2.5 (2.3-3.3) 6.3 (5.2-7.3) 6.1 (5.1-7.2) 10.9 (10.1-12.1) 10.9 (9.8-12.3) 19.3 (18.4-20.5) 19.2 (18.1-20.3) 
Male Sex % (n)                     49% (155) 49% (155) 48% (135) 51% (122) 44% (71) 46% (101) 42% (64) 47% (61) 38% (25) 
Gestational age Mean (SD) 24.9 (0.7) 24.9 (0.7) 24.9 (0.7) 24.9 (0.7) - 24.9 (0.7) - 24.9 (0.8) - 
  <=23 weeks  % (n)                     9% (29) 9% (29) 9% (26) 10% (24) - 11% (23) - 11% (15) - 
  24 weeks % (n)                     32% (100) 32% (100) 32% (90) 30% (73)  32% (70)  29% (37)  
  25 weeks % (n) 59% (186) 59% (186) 59% (167) 60% (144) - 57% (126) - 60% (77) - 
Neonatal Brain injury  % (n/N) 23% (71/314) 23% (71/314) 22% (63/283) 22% (54/241) - 22% (49/218) - 17% (22/128) - 
Growth parameters           
Height  (cm) 
Mean 
 (95%CI) 
- - 
88.6 
 (88.1, 89.1) 
[n=258] 
112.7 
 (111.9,113.5) 
[n=237] 
116.2 
 (115.2,117.2) 
[n=159] 
139.7 
 (138.7,140.6) 
[n=218] 
144.5 
 (143.3,145.8) 
[n=153] 
163.7 
 (162.0,165.3) 
[n=129] 
167.7 
 (165.6,169.7) 
[n=65] 
  Difference in means   (95%CI) - - - -3.5 (-4.8, -2.3) -4.9 (-6.4, -3.3) -4.0 (-6.8,  -1.3) 
Height z-score 
Mean 
 (95%CI) 
- - 
-0.70 
 (-0.84, -0.55) 
[n=258] 
-0.95 
 (-1.09, -0.81) 
[n=237] 
-0.00 
 (-0.17,  0.17) 
[n=159] 
-0.55 
 (-0.69, -0.41) 
[n=218] 
0.15 
 (-0.01,  0.32) 
[n=153] 
-0.98 
 (-1.19, -0.78) 
[n=129] 
-0.18 
 (-0.42,  0.06) 
[n=65] 
  Difference in means    (95%CI) - - - -0.95 ( -1.16, -0.73) -0.71 ( -0.92, -0.50) -0.81 ( -1.14, -0.47) 
Weight  (kg) 
Mean 
 (95%CI) 
0.75 (0.73, 0.76) 
[n=315] 
2.57 (2.51,  2.62) 
[n=306] 
11.9 (11.7, 12.1) 
[n=271] 
18.8 (18.3, 19.3) 
[n=241] 
21.6 (21.0, 22.3) 
[n=159] 
34.1 (33.0, 35.2) 
[n=217] 
38.4 (36.8, 40.0) 
[n=152] 
  62.8 (60.4, 
65.2)  
[n=128] 
69.6 ( 65.2, 
74.1) 
[n=65] 
  Difference in means    (95%CI) - - - -2.8 (-3.6, -2.0) -4.3 (-6.1, -2.4) -6.8 (-11.4, -2.3) 
Weight z-score 
Mean 
 (95%CI) 
-0.18  
(-0.26, -0.09) 
[n=312] 
-1.69  
(-1.81, -1.57) 
[n=299] 
-1.19  
(-1.35, -1.03) 
[n=271] 
-1.18  
(-1.35, -1.01) 
[n=241] 
0.07  
(-0.12, 0.25) 
[n=159] 
-0.42  
(-0.59, -0.25) 
[n=217] 
0.21  
(0.02, 0.39) 
[n=152] 
-0.25 
 (-0.51, -0.00) 
[n=128] 
0.54 
  (0.18,  0.89) 
[n=65] 
  Difference in means    (95%CI) - - - -1.25 ( -1.51, -0.99) -0.62 ( -0.88, -0.37) -0.79 ( -1.22, -0.36) 
BMI  (kg/m2) 
Mean 
 (95%CI) 
- - 
15.1 (14.9, 15.3) 
[n=253] 
14.6 (14.4, 14.8) 
[n=237] 
15.9 (15.6, 16.2) 
[n=158] 
17.3 (16.9, 17.7) 
[n=217] 
18.2 (17.6, 18.7) 
[n=152] 
23.3 (22.6, 24.1) 
[n=128] 
24.7 (23.3, 26.1) 
[n=65] 
  Difference in means    (95%CI) - - - -1.3 (-1.7, -1.0) -0.9 (-1.5, -0.2) -1.3 (-2.8, 0.1) 
BMI z-score 
Mean 
 (95%CI) 
- - 
-1.00 (-1.17, -0.83) 
[n=253] 
-0.87 (-1.03, -
0.70) 
[n=237] 
0.11 (-0.07, 
0.29) 
[n=158] 
-0.22 (-0.40, -
0.03) 
[n=217] 
0.17 (-0.03, 
0.37) 
[n=152] 
0.32 (0.08,  0.56) 
[n=128] 
0.69 (0.36,  
1.02) 
[n=65] 
  Difference in means    (95%CI) - - - -0.98 ( -1.23, -0.73) -0.39 ( -0.66, -0.11) -0.37 ( -0.78,  0.04) 
Head circumference  
(cm) 
Mean 
 (95%CI) 
23.3 
 (23.1, 23.5) 
[n=209] 
33.3 
 (33.1, 33.6) 
[n=293] 
48.3  
(48.1, 48.6) 
[n=278] 
50.6  
(50.3, 50.8) 
[n=239] 
52.2  
(52.0, 52.4) 
[n=160] 
52.5  
(52.3, 52.8) 
[n=217] 
54.3  
(54.1, 54.5) 
[n=152] 
55.0  
(54.7, 55.4) 
[n=125] 
56.6  
(56.1, 57.0) 
[n=63] 
  Difference in means    (95%CI) - - - -1.6 (-2.0, -1.3) -1.8 (-2.1, -1.4) -1.5(-2.1, -0.9) 
Head circumference z-
score 
Mean 
 (95%CI) 
-0.24 
 ( -0.42, -0.06) 
[n=207] 
-0.88 
 ( -1.06, -0.70) 
[n=287] 
-1.56  
(-1.74, -1.39) 
[n=278] 
-1.63  
(-1.79, -1.46) 
[n=239] 
-0.33  
(-0.49, -0.17) 
[n=160] 
-1.27  
(-1.44, -1.10) 
[n=217] 
-0.01  
(-0.17, 0.14) 
[n=152] 
-0.84 
 (-1.07, -0.61) 
[n=125] 
0.29 
 (0.02,  0.55) 
[n=63] 
  Difference in means    (95%CI) - - - -1.30 (-1.54, -1.06) -1.26 (-1.50, -1.02) -1.13 (-1.50, -0.75) 
+Growth measures corrected for prematurity at 2.5 years
16 
 
Table 2 Estimated mean differences and 95% confidence intervals in z-scores for growth parameters from multilevel 
modelling analyses in extremely preterm (EP) participants and term-born controls a 
(a)     
Parameter Height z-score Weight z-score BMI z-score 
Head circumference z-
score 
 Unadjusted model b 
 (n=489) 
Unadjusted model b 
 (n=491) 
Unadjusted model b 
 (n=486) 
Unadjusted model b 
 (n=493) 
 Estimate (95% CI) Estimate (95% CI) Estimate (95% CI) Estimate (95% CI) 
EP (ref.=controls) c -0.83 (-1.01, -0.64) -0.94 (-1.15, -0.73) -0.78 (-1.00, -0.56) -1.22 (-1.43, -1.02) 
Age at assessment d -0.00 (-0.01, 0.00) 0.06 (0.05, 0.07) 0.05 (0.02, 0.07) 0.04 (0.03, 0.05) 
EP*Age - - 0.04 (0.01, 0.07) - 
(b)     
 Adjusted for sex e 
 (n=489) 
Adjusted for sex e 
 (n=491) 
Adjusted for sex e 
 (n=486) 
Adjusted for sex e 
 (n=493) 
 Estimate (95% CI) Estimate (95% CI) Estimate (95% CI) Estimate (95% CI) 
EP (ref.=controls) c -0.82 (-1.01, -0.64) -0.94 (-1.15, -0.73) -0.78 (-1.00, -0.56) -1.22 (-1.43, -1.02) 
Age at assessment d  -0.00 (-0.01, 0.00) 0.06 (0.05, 0.07) 0.05 (0.02, 0.07) 0.04 (0.03, 0.05) 
EP*Age - - 0.04 (0.01, 0.07) - 
Male (ref.=female) -0.05 (-0.23, 0.13) 0.02 (-0.18, 0.23) 0.06 (-0.14, 0.26) -0.00 (-0.20, 0.20) 
a For all models, age was centred at 6 years to make intercept coefficients more meaningful.  
b  Variables in the model: group status (EP participants or controls), age at assessment and group*age interaction. Interactions were only 
shown if significant. Trajectories of height, weight and head circumference z-scores were similar in the EP and control groups. The group*age 
interaction was significant for BMI z-scores, indicating that the trajectory of BMI z-scores was different in the two groups. 
c Estimates represent mean differences in growth measure z-scores between EP participants and controls. 
d Estimates represent estimated average changes in growth measure z-scores over time: for instance, on average, weight increased by 0.06 SD 
per year and head circumference increased by 0.04 SD per year.  
e Sex was further adjusted for to examine whether it would affect growth trajectories in the two groups. The group*sex interactions were 
insignificant (not shown), which indicates similar trajectories between females and males in both groups.  
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Table 3 Multi-level modelling: factors associated with growth trajectories within EP participants a 
Variables Height z-score  (Unadjusted) 
Height z-score  (Adjusted b) 
 (n=277) 
 Estimate  (95% CI) p Estimate (95% CI) p 
Gestational age  (per week) 0.05 (-0.11,0.21) [n=287] 0.546 - - 
Moderate-severe brain injury (ref.=minor/none) -0.26 (-0.54,0.02) [n=286] 0.068 - - 
Birthweight z-score  (per SD) 0.28 (0.13,0.43) [n=284] <0.001 0.27 (0.13,0.41) <0.001 
White ethnicity (ref.=other ethnicities) -0.65 (-0.94,-0.37) [n=287] <0.001 -0.65 (-0.92,-0.38) <0.001 
Ethnicity*Agec 0.02 (0.00,0.05) [n=287] 0.041 0.03 (0.01,0.05) 0.007 
Enteral feeding begun before day 7 (ref.=no) 0.33 (0.09,0.56) [n=279] 0.006 0.35 (0.13,0.57) 0.002 
Enteral feeding*Agec -0.02 (-0.04,-0.00) [n=279] 0.017 -0.02 (-0.04,-0.00) 0.011 
Steroids for chronic lung disease  (per week) -0.03 (-0.07,0.01) [n=282] 0.133 - - 
 Weight z-score  (Unadjusted) 
Weight z-score  (Adjusted b) 
 (n=280) 
 Estimate (95% CI) p Estimate (95% CI) p 
Gestational age  (per week) -0.01 (-0.20,0.18) [n=290] 0.919 - - 
Moderate-severe brain injury (ref.=minor/none) -0.15 (-0.47,0.17) [n=289] 0.363 - - 
Birthweight z-score (per SD) 0.29 (0.12,0.17) [n=287] 0.001 0.28 (0.11,0.45) 0.001 
Birthweight z-score*Agec -0.03 (-0.04,-0.01) [n=287] 0.005 -0.03 (-0.05,-0.01) 0.003 
White ethnicity (ref.= other ethnicities) -0.63 (-0.95,-0.30) [n=290] <0.001 -0.63 (-0.95,-0.32) <0.001 
Ethnicity*Agec 0.04 (0.00,0.07) [n=290] 0.030 0.04 (0.01,0.08) 0.015 
Enteral feeding begun before day 7 (ref.=no) 0.42 (0.15,0.68) [n=282] 0.002 0.45 (0.19,0.70) 0.001 
Steroids for chronic lung disease  (per week) -0.03 (-0.07,0.01) [n=285] 0.141 - - 
 BMI z-score  (Unadjusted) 
BMI z-score  (Adjusted b) 
 (n=276) 
 Estimate (95% CI) p Estimate (95% CI) p 
Gestational age  (per week) -0.02 (-0.20,0.16) [n=286] 0.813 - - 
Moderate-severe brain injury (ref.=minor/none) -0.01 (-0.32,0.31) [n=285] 0.970 - - 
Birthweight z-score  (per SD) 0.13 (-0.04,0.30) [n=283] 0.144 0.13 (-0.04,0.31) 0.133 
Birthweight z-score*Agec -0.02 (-0.04,-0.00) [n=283] 0.017 -0.03 (-0.05,-0.01) 0.014 
White ethnicity (ref.= other ethnicities) -0.13 (-0.44,0.19) [n=286] 0.432 - - 
Enteral feeding begun before day 7 (ref.=no) 0.30 (0.03,0.56) [n=278] 0.026 0.29 (0.03,0.56) 0.028 
Steroids for chronic lung disease  (per week) -0.01 (-0.05,0.03) [n=281] 0.708 - - 
 Head circumference z-score (Unadjusted) 
Head circumference z-score (Adjusted b) 
 (n=276) 
 Estimate (95% CI) p Estimate (95% CI) p 
Gestational age  (per week) 0.25 (0.05,0.44) [n=290] 0.013 0.46 (0.25,0.67) <0.001 
Moderate-severe brain injury (ref.=minor/none) -0.19 (-0.53,0.16) [n=289] 0.289 - - 
Birthweight z-score  (per SD) 0.31 (0.13,0.49) [n=287] 0.001 0.38 (0.19,0.56) <0.001 
White ethnicity (ref.= other ethnicities) 0.13 (-0.22,0.48) [n=290] 0.467 - - 
Enteral feeding begun before day 7 (ref.=no) 0.38 (0.09,0.66) [n=282] 0.009 0.30 (0.02,0.57) 0.033 
Steroids for chronic lung disease  (per week) -0.05 (-0.10,-0.01) [n=285] 0.020 -0.04 (-0.08,0.00) 0.079 
a For all models, age was centred at 6 years to make intercept coefficients more meaningful. One variable each time in the unadjusted models. 
For continuous variables (e.g., birthweight z-score), estimate refers to estimated change in growth measure z-scores for per unit change in the 
predictor. For categorical variables, it refers to estimated difference in means relative to the reference group. 
b Adjusted for age and variables with a p value <0.05 in the unadjusted models.  
c Interactions with age at assessment were shown if significant. Significant interactions indicate that the impact of the predictor on the growth 
outcomes differed with age at assessment. 
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